{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:27:16Z","timestamp":1787023636472,"version":"build-2736575974"},"reference-count":49,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,10]]},"DOI":"10.18632\/oncotarget.12699","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T00:32:37Z","timestamp":1476577957000},"page":"1957-1971","source":"Crossref","is-referenced-by-count":44,"title":["The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?"],"prefix":"10.18632","volume":"8","author":[{"given":"Marie","family":"Eliade","sequence":"first","affiliation":[{"name":"Centre of Genetic, Children Hospital, CHU, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Skrzypski","sequence":"additional","affiliation":[{"name":"Oncogenetic Unit, Centre Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Baurand","sequence":"additional","affiliation":[{"name":"Centre of Genetic, Children Hospital, CHU, Dijon, France"},{"name":"Oncogenetic Unit, Centre Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Jacquot","sequence":"additional","affiliation":[{"name":"Centre of Genetic, Children Hospital, CHU, Dijon, France"},{"name":"Oncogenetic Unit, Centre Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Bertolone","sequence":"additional","affiliation":[{"name":"Centre of Genetic, Children Hospital, CHU, Dijon, France"},{"name":"Oncogenetic Unit, Centre Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Loustalot","sequence":"additional","affiliation":[{"name":"Gynecological Surgery, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Coutant","sequence":"additional","affiliation":[{"name":"Gynecological Surgery, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"},{"name":"Burgundy Franche-Comt\u00e9 University, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"France","family":"Guy","sequence":"additional","affiliation":[{"name":"Radiology unit, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fumoleau","sequence":"additional","affiliation":[{"name":"Medical Oncology, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"},{"name":"Burgundy Franche-Comt\u00e9 University, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis","family":"Duffourd","sequence":"additional","affiliation":[{"name":"Orphanomix, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnould","sequence":"additional","affiliation":[{"name":"Biology and Tumor Pathology Department, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Delignette","sequence":"additional","affiliation":[{"name":"Elithis Tower, Radiology, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Martine","family":"Pad\u00e9ano","sequence":"additional","affiliation":[{"name":"Gynecological Surgery, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00f4me","family":"Lepage","sequence":"additional","affiliation":[{"name":"Hepato-Gastroenterology and Digestive Oncology, Fran\u00e7ois Mitterand Hospital, CHU, Dijon, France"},{"name":"Burgundy Franche-Comt\u00e9 University, INSERM LNC UMR866, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Raichon-Patru","sequence":"additional","affiliation":[{"name":"Oncology, Les Chanaux Hospital, Macon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axelle","family":"Boudrant","sequence":"additional","affiliation":[{"name":"Oncology, William Morey Hospital, Chalon-sur-Sa\u00f4ne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"B\u00f4ne-L\u00e9pinoy","sequence":"additional","affiliation":[{"name":"Oncology, Drevon Clinic, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Villing","sequence":"additional","affiliation":[{"name":"Oncology, Hospital, Auxerre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Charpin","sequence":"additional","affiliation":[{"name":"Centre of Genetic, Children Hospital, CHU, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Peignaux","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Chevrier","sequence":"additional","affiliation":[{"name":"Platform of Transfer in Cancer Biology, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Vegran","sequence":"additional","affiliation":[{"name":"Platform of Transfer in Cancer Biology, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Ghiringhelli","sequence":"additional","affiliation":[{"name":"Medical Oncology, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"},{"name":"Platform of Transfer in Cancer Biology, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Boidot","sequence":"additional","affiliation":[{"name":"Platform of Transfer in Cancer Biology, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sevenet","sequence":"additional","affiliation":[{"name":"Bergoni\u00e9 Institute, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarab","family":"Lizard","sequence":"additional","affiliation":[{"name":"Biology and Tumor Pathology Department, Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Faivre","sequence":"additional","affiliation":[{"name":"Centre of Genetic, Children Hospital, CHU, Dijon, France"},{"name":"Oncogenetic Unit, Centre Georges-Fran\u00e7ois Leclerc Centre, Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/PPO.0b013e31826246c2","article-title":"Genetic testing by cancer site ovary","volume":"18","author":"Newlin","year":"2012","journal-title":"Cancer J"},{"key":"2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13402-011-0010-3","article-title":"Pathology of hereditary breast cancer","volume":"34","author":"Van Diest","year":"2011","journal-title":"Cell Oncol"},{"key":"3","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-Panel Sequencing and the prediction of breast-Cancer Risk","volume":"372","author":"Chenevix-Trench","year":"2015","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Manoukian","year":"2003","journal-title":"Am J Hum Genet"},{"key":"5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Jemal","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Parmigiani","year":"2007","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Cole","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"8","first-page":"676","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Struewing","year":"1998","journal-title":"The Breast Cancer Linkage Consortium"},{"key":"9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","article-title":"Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer","volume":"295","author":"King","year":"2006","journal-title":"JAMA"},{"key":"10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","article-title":"High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome","volume":"50","author":"Dugast","year":"2013","journal-title":"J Med Genet"},{"key":"11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/gast.2000.20228","article-title":"Very high risk of cancer in familial Peutz-Jeghers syndrome","volume":"119","author":"Tersmette","year":"2000","journal-title":"Gastroenterology"},{"key":"12","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families","author":"Caldas","year":"2001","journal-title":"Gastroenterology"},{"key":"13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.6004\/jnccn.2016.0018","article-title":"Genetic\/Familial High-Risk Assessment: Breast and Ovarian, Version 2. 2015","volume":"14","author":"Kurian","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"14","doi-asserted-by":"crossref","first-page":"e0130393","DOI":"10.1371\/journal.pone.0130393","article-title":"Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers","volume":"10","author":"Lubinski","year":"2015","journal-title":"PLoS One"},{"key":"15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10549-011-1443-0","article-title":"BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer","volume":"127","author":"Scott","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"16","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2006","journal-title":"Nat Genet"},{"key":"17","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Garcia","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Hartman","year":"2015","journal-title":"Cancer"},{"key":"19","article-title":"Improving performance of multigene panels for genomic analysis of cancer predisposition","author":"Pritchard","year":"2016","journal-title":"Genet Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","article-title":"Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2","volume":"137","author":"Monk","year":"2015","journal-title":"Gynecol Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gim.2014.176","article-title":"Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer","volume":"17","author":"Nathanson","year":"2015","journal-title":"Genet Med"},{"key":"22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ejhg.2014.16","article-title":"Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes","volume":"22","author":"Bera","year":"2014","journal-title":"European Journal of Human Genetics"},{"key":"23","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","author":"Pineda-Alvarez","year":"2015","journal-title":"Genet Med"},{"key":"24","first-page":"208","article-title":"Clinical application of multigene panels : Challenges of next-generation counseling and cancer risk management. Front","volume":"5","author":"Weitzel","year":"2015","journal-title":"Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment","volume":"1","author":"Ellisen","year":"2015","journal-title":"JAMA Oncol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment","volume":"32","author":"Ford","year":"2014","journal-title":"J Clin Oncol"},{"key":"27","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","article-title":"Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care","volume":"34","author":"Campbell","year":"2016","journal-title":"J Clin Oncol"},{"key":"28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-015-3429-9","article-title":"HBOC multi-gene panel testing: comparison of two sequencing centers","volume":"152","author":"Wimberger","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"29","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Garcia","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients","volume":"16","author":"Chao","year":"2014","journal-title":"Genet Med"},{"key":"31","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Guidugli","year":"2015","journal-title":"J Clin Oncol"},{"key":"32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2307\/3578071","article-title":"Assessment of chronic gamma radiosensitivity as an in vitro assay for heterozygote identification of ataxia-telangiectasia","volume":"128","author":"Gatti","year":"1991","journal-title":"Radiat Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF00124257","article-title":"Heterogeneity in the clastrogenic response to X-rays in the Lymphocytes from Ataxia-telangiectasia heterozygotes and controls","volume":"3","author":"Kelsey","year":"1992","journal-title":"Cancer Causes Control"},{"key":"34","first-page":"e93211","article-title":"Assessment of targeted and Non-targeted responses in cells deficient in ATM function following exposure to low and high dose X-rays","volume":"3","author":"Launonen","year":"2014","journal-title":"Plos One"},{"key":"35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.2013.1438","article-title":"The indispensable role of professional judgment in genomic medicine","volume":"309","author":"Evans","year":"2013","journal-title":"JAMA"},{"key":"36","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2013.1468","article-title":"Accessing genomic medicine: affordability, diffusion, and disparities","volume":"309","author":"De Sa","year":"2013","journal-title":"JAMA"},{"key":"37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2015.12.005","article-title":"Ovarian cancer in Lynch syndrome; a systematic review","volume":"55","author":"De Bock","year":"2016","journal-title":"Eur J Cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","article-title":"Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2","volume":"137","author":"Monk","year":"2015","journal-title":"Gynecol Oncol"},{"key":"39","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1200\/JCO.2011.39.5590","article-title":"Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study","volume":"30","author":"Southey","year":"2012","journal-title":"J Clin Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/bcr3405","article-title":"Risk of breast cancer in Lynch syndrome: a systematic review","volume":"15","author":"Jenkins","year":"2013","journal-title":"Breast Cancer Res"},{"key":"41","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/humu.20318","article-title":"Long-range PCR facilitates the identification of PMS2-specific mutations","volume":"27","author":"LaJeunesse","year":"2006","journal-title":"Hum Mutat"},{"key":"42","first-page":"588","article-title":"Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes","volume":"31","author":"Swensen","year":"2010","journal-title":"Hum Mutat"},{"key":"43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1200\/JCO.2014.57.8088","article-title":"Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk","volume":"33","author":"Mensenkamp","year":"2015","journal-title":"J Clin Oncol"},{"key":"44","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer","volume":"373","author":"Sandhu","year":"2015","journal-title":"N Engl J Med"},{"key":"45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Durbin","year":"2010","journal-title":"Bioinformatics"},{"key":"46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"Kernytsky","year":"2011","journal-title":"Nat Genet"},{"key":"47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Rehm","year":"2015","journal-title":"Genet Med"},{"key":"48","first-page":"1267","article-title":"Multiplex genetic testing for cancer susceptibility: Out on the high wire without a net?","volume":"31","author":"Garber","journal-title":"J Clin Oncol"},{"key":"49","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/jama.2013.1414","article-title":"Genomic medicine, health information technology, and patient care","volume":"309","author":"Kohane","year":"2013","journal-title":"JAMA"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T09:40:09Z","timestamp":1589103609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,15]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1,10]]}},"alternative-id":["12699","27779110"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12699","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,15]]}}}